People: Carlo Croce, Richard Smalley Receive 1993 John Scott Awards, Presented By City Of Philadelphia To Honor Pioneering Work

Awards, Presented By City Of Philadelphia To Honor Pioneering Work Carlo M. Croce, director of the Thomas Jefferson University Cancer Institute and Cancer Center in Philadelphia, and Richard E. Smalley, Gene and Norman Hackerman Professor of Chemistry at Rice University in Houston, have received the 1993 John Scott Awards, presented by the Board of City Trusts of the city of Philadelphia on November 19. The award is given annually for inventions that "contribute to the comfort, welfare, and ha

Written byCraig Montesano
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Croce was recognized for his pioneering research into human cancer, particularly in combining cytogenetics and gene mapping to identify the genetic mechanisms underlying abnormal cell growth. He was also responsible for the identification of previously unrecognized oncogenes in B- cell tumors.

In his acceptance speech, Croce acknowledged that his research was "the logical continuation of something that happened here in the city of Philadelphia--the discovery, in 1960, of the Philadelphia chromosome." The Philadelphia chromosome, a crucial link to several types of cancer and tumors, as well as to mental retardation and other disorders, was first described by Peter C. Howell and David A. Hungerford (Science, 132:1497, 1960). Hunger-ford died last month (The Scientist, Nov. 29, 1993, page 22).

Assessing that breakthrough, which presented evidence of genetic changes in cancer cells, led Croce to apply "modern technology in molecular biology to identify the genes that are involved in cancer," he said.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies